Beta-O2 Technologies Ltd.
Implantable bioartificial pancreas for type 1 diabetes
This article was originally published in Start Up
Executive Summary
Beta-O2 Technologies Ltd.’s bioartificial pancreas, βAir, implanted under the skin, is a small macroencapsulation system that is loaded with pancreatic endocrine cells that control the body’s insulin and glucagon production.